Loading patent…
OwnerPaul Kellam, Anne Palser +11inventors
InventorsPaul Kellam, Anne Palser, Volker Germaschewski, Simon James Watson, Benjamin David Grimshaw, Spela Binter, Jaroslaw Michal Szary, Margot Billaud, Robert Rowlands, Aishwarya Krishna, Huan-Chun Lin, Cheng-Yuan Yang, Li-Ying Liou
Estimating the term…
The present invention relates to antibodies that are specific for SARS-CoV-2. The present invention also provides methods of treatment, uses, pharmaceutical compositions and kits comprising the antibodies.
A neutralising antibody that specifically binds to the receptor binding domain (RBD) of a SARS-CoV-2 spike protein, wherein the antibody competes for binding to the SARS-CoV-2 spike protein with a human ACE2 receptor.
(canceled)
-23. (canceled)
(canceled)
-30. (canceled)
(canceled)
-39. (canceled)
-49. (canceled)
-55. (canceled)
(canceled)
-63. (canceled)
-72. (canceled)
Dependencies are inferred from the claim text.